Test Price
2,800 AED✅ Home Collection Available
SOST Gene Sclerosteosis Type 1 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Comprehensive NGS analysis for Sclerosteosis Type 1 with premium logistics and clinical support.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This test uses Next‑Generation Sequencing (NGS) to fully analyse the SOST gene, detecting pathogenic variants responsible for the rare autosomal recessive bone disorder Sclerosteosis type 1. The result provides essential diagnostic and prognostic information for paediatric, orthopaedic, and genetic management.
| Feature | Our Test (NGS SOST) | Sanger Sequencing | Whole Exome Sequencing |
|---|---|---|---|
| Precision | Full gene coverage, detects novel variants, >99.9% sensitivity | Limited to known hotspots, may miss large deletions | Broad capture but lower depth for SOST, incidental findings risk |
| Methodology | Next‑Generation Sequencing (NGS) | Capillary Electrophoresis | NGS with Exome Capture |
| Turnaround Time | 3–4 Weeks | 2–4 Weeks | 6–10 Weeks |
Physician Insight & Safety Protocols
“I am Lina Osama Zaki Quteineh, Consultant Medical Genetics with DHA Registration ID 9294403. This highly sensitive NGS test is a powerful tool for confirming Sclerosteosis, but genetic results must always be interpreted alongside clinical and radiological findings. I urge you to review the outcome with a paediatric geneticist to understand its full implications for care and family screening. Never adjust any prescribed therapy based solely on this report.”
Advisory Notice
Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Not suitable for prenatal diagnosis without prior validation in an accredited prenatal laboratory.
- Individuals undergoing recent blood transfusion or with haematological malignancy should delay testing.
- ⚠️ Seek immediate medical attention if you experience sudden vision loss, severe headaches, or signs of increased intracranial pressure (papilledema) – skull base thickening may cause neurological emergencies.
- Do not use heparin tubes for blood collection; only EDTA or DNA‑stabilizing FTA cards.
Patient FAQ & Clinical Guidance
1. What is the SOST gene NGS test?
The SOST gene NGS test analyses your DNA for mutations causing Sclerosteosis type 1, a rare bone overgrowth disorder. It sequences the entire coding region of the SOST gene to detect pathogenic variants, allowing early diagnosis and family counselling.
2. How is the test performed?
A small blood sample (or one drop on an FTA card) is collected by a certified phlebotomist during home visit. The DNA is extracted and analysed using high‑throughput NGS, ensuring comprehensive mutation detection with a turnaround of 3–4 weeks.
3. How to interpret the results?
A positive report means a disease‑causing SOST variant was found, confirming Sclerosteosis type 1 with 99.9% diagnostic sensitivity. Negative results reduce the likelihood but cannot completely rule out the condition; clinical correlation remains essential.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Accreditation
This test is conducted in strict compliance with the following UAE federal laws:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
All procedures adhere to the highest data security and patient consent standards. Facility licensed by DHA (License No. 1143) and operated under ISO 9001:2015 quality management (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | SOST Gene Sclerosteosis Type 1 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Q78.8 |
| LOINC Code | 33811-0 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians